The Food and Drug Administration announced today it is investigating the risk of brain deposits for patients who are given repeated MRIs using imaging drugs that contain a heavy metal. The FDA did not announce any label changes for the nine medicines that contain the metal, gadolinium, saying there was a “need for additional information.” However, “to reduce the potential …
Left in the Brain: Potentially Toxic Residue from MRI Drugs by Jeff Gerth
With a family history of breast cancer, Marcie Jacobs decided in June 2001 that an MRI screening was her best preventive option. As is common with MRIs, Jacobs was injected beforehand with a contrast agent, a drug that helps sharpen the resulting images. But after a few of these treatments, she began noticing some strange cognitive effects. Jacobs began missing …